Hisamitsu Pharmaceutical Co., Inc.

FDA inspection history in Tosu, Japan, 2019

1
Form 483

Every document, by year

  • Form 483

2019: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2019One Form 483, at Tosu, Japan.

Cited most

Across all Hisamitsu Pharmaceutical Co. observations on file

The complete Hisamitsu Pharmaceutical Co. file.

All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.

$99

The documents one by one, while the file is prepared

See the documents

Sites

Documents

1 on file, newest first
DateDocumentPrice
2019-05-31483 Form 483$99

Investigators on these documents

Caroline Strasinger (1)Saundrea A. Munroe (1)

FEI number 1000266995 · most recent document May 31, 2019

About Hisamitsu Pharmaceutical Co., Inc.

How many FDA Form 483s has Hisamitsu Pharmaceutical Co., Inc. received?

FDA Intel has 1 Form 483 on file for Hisamitsu Pharmaceutical Co., Inc.; the most recent is dated May 31, 2019.

When was Hisamitsu Pharmaceutical Co., Inc. last inspected by FDA?

The most recent FDA inspection document on file for Hisamitsu Pharmaceutical Co., Inc. is a Form 483 dated May 31, 2019, for the site in Tosu, Japan.

What did FDA cite at Hisamitsu Pharmaceutical Co., Inc.?

The regulations cited most in the observations on file for Hisamitsu Pharmaceutical Co., Inc. are 21 CFR 211.165 (Testing and release for distribution), 2 times; 21 CFR 211.192 (Production record review), 2 times; 21 CFR 211.160 (General requirements), 1 time.